Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 07/19/2024
Closing price: 72.56
Support price level: | $68.63 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 69.8 |
Beta | 0.29 |
- The price of this low-beta stock is expected to increase by 0.29% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$63.15 | $87.29 | 42.9% |
200 day | 50 day | 20 day | 10 day |
$73.50 | $67.14 | $69.69 | $70.58 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
25.9% | 20.8% | 28.7% | 26.9% |
- 7.8% in the next week.
- 15.2% in the next month.
- 45.8% in the next year.
Company news for Gilead Sciences Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks